A Pharmacoepidemiologic analysis of the impact of calendar packaging on adherence to self-administered medications for long-term use

Clinical Therapeutics

Volumn 33, Issue 5, 2011, Pages 581-597

  Zedler, Barbara K ^a   Joyce, Andrew ^a   Murrelle, Lenn ^a   Kakad, Priyanka ^b   Harpe, Spencer E ^b  

^a Venebio Group LLC   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Calendar packaging; Medication adherence; Pharmacoepidemiology; Pharmacy claims analysis

Indexed keywords

ENALAPRIL; ENALAPRIL PLUS HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; LISINOPRIL;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DRUG PACKAGING; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PHARMACOEPIDEMIOLOGY; PHARMACY; PRESCRIPTION; RETROSPECTIVE STUDY; TREATMENT DURATION;

ANTIHYPERTENSIVE AGENTS; DRUG PACKAGING; HEART FAILURE; HUMANS; HYPERTENSION; PATIENT COMPLIANCE; SELF ADMINISTRATION;

EID: 79958713685     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2011.04.020     Document Type: Article

References (55)

1. Cramer J.A., Roy A., Burrell A., et al. Medication compliance and persistence: terminology and definitions. Value Health 2008, 11:44-47.
2. George J., Elliott R.A., Stewart D.C. A systematic review of interventions to improve medication taking in elderly patients prescribed multiple medications. Drugs Aging 2008, 25:307-324.
3. Haynes R.B., Ackloo E., Sahota N., et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008, 1:CD000011.
4. Heneghan C.J., Glasziou P., Perera R. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev 2006, 1:CD005025.
5. Cramer J., Spilker B. Patient Compliance in Medical Practice and Clinical Trials 1991, 414. Raven Press, New York, NY.
6. Haynes R.B. A critical review of the determinants of compliance. Compliance with Therapeutic Regimens 1976, Johns Hopkins University Press, Baltimore, Md. D.L. Sackett, R.B. Haynes (Eds.).
7. Steiner J.F., Prochazka A.V. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997, 50:105-116.
8. Steiner J.F., Ho P.M., Beaty B.L., et al. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes 2009, 2:451-457.
9. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med 2005, 353:487-497.
10. Steiner J.F. Can we identify clinical predictors of medication adherence... and should we?. Med Care 2010, 48:193-195.
11. Sabate E. Adherence to Long-Term Therapies: Evidence for Action 2003, World Health Organization, Geneva, Switzerland.
12. Aspden P., Wolcott J., Bootman J., et al. Preventing Medication Errors 2007, Institute of Medicine, Washington, DC.
13. Enhancing prescription medicine adherence: a national action plan National Council on Patient Information and Education, Accessed March 5, 2011. http://www.talkaboutrx.org/documents/enhancing_prescription_medicine_adherence.pdf.
14. Kripalani S., Gatti M.E., Jacobson T.A. Association of age, health literacy, and medication management strategies with cardiovascular medication adherence. Patient Educ Couns 2010, 81:177-181.
15. Roter D.L., Hall J.A., Merisca R., et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998, 36:1138-1161.
16. Schroeder K., Fahey T., Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care?. Systematic review of randomized controlled trials. Arch Intern Med 2004, 164:722-732.
17. Zedler B., Kakad P., Colilla S., et al. Does packaging with a calendar feature improve adherence to self-administered medication for long-term use?. A systematic review. Clin Ther 2011, 33:62-73.
18. Study finds no association between oral contraceptive use and breast cancer for women 35 and over [press release] Centers for Disease Control and Prevention, Accessed March 5, 2011. http://www.cdc.gov/media/pressrel/r020626.htm.
19. Schneider P.J., Murphy J.E., Pedersen C.A. Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients. J Am Pharm Assoc 2008, 48:58-63.
20. Dreyer N.A., Schneeweiss S., McNeil B.J., et al. GRACE principles: recognizing high-quality observational studies of comparative effectiveness. Am J Manag Care 2010, 16:467-471.
21. Guidelines for good pharmacoepidemiology practices. Pharmacoepidemiol and Drug Safety 2008, 17:200-208. International Society for Pharmacoepidemiology.
22. Peterson A.M., Nau D.P., Cramer J.A., et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007, 10:3-12.
23. Avorn J., Monette J., Lacour A., et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA 1998, 279:1458-1462.
24. Shrank W.H., Hoang T., Ettner S.L., et al. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med 2006, 166:332-337.
25. Hess L.M., Raebel M.A., Conner D.A., et al. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006, 40:1280-1288.
26. Hansen R.A., Kim M.M., Song L., et al. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother 2009, 43:413-422.
27. Wu J.R., Moser D.K., De Jong M.J., et al. Defining an evidence-based cutpoint for medication adherence in heart failure. Am Heart J 2009, 157:285-291.
28. Sackett D.L., Haynes R.B., Gibson E.S., et al. Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet 1975, 1:1205-1207.
29. Mazzaglia G., Ambrosioni E., Alacqua M., et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009, 120:1598-1605.
30. Ray W.A. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003, 158:915-920.
31. Johnson M.L., Crown W., Martin B.C., et al. Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report-Part III. Value Health 2009, 12:1062-1073.
32. The R project for statistical computing Accessed March 5, 2011. http://www.r-project.org/.
33. Harrell F.E. rms: regression modeling strategies Accessed March 5, 2011. http://cran.r-project.org/web/packages/rms/index.html.
34. Ho D., Imai K., King G., et al. Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Political Analysis 2007, 15:199-236.
35. Cox E., Martin B.C., Van Staa T., et al. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report-Part II. Value Health 2009, 12:1053-1061.
36. Martin A., Lassman D., Whittle L., et al. Recession contributes to slowest annual rate of increase in health spending in five decades. Health Aff (Millwood) 2011, 30:11-22.
37. Holahan J. The 2007-09 recession and health insurance coverage. Health Aff (Millwood) 2011, 30:145-152.
38. National economic indicators Bureau of Economic Analysis/Haver Analytics, Accessed March 5, 2011. http://www.richmondfed.org/research/national_economy/national_economic_indicators/index.cfm%23tabview=tab3.
39. Chan D.C., Shrank W.H., Cutler D., et al. Patient, physician, and payment predictors of statin adherence. Med Care 2010, 48:196-202.
40. Connor J., Rafter N., Rodgers A. Do fixed-dose combination pills or unit-of-use packaging improve adherence?. A systematic review. Bull World Health Organ 2004, 82:935-939.
41. Maronde R.F., Chan L.S., Larsen F.J., et al. Underutilization of antihypertensive drugs and associated hospitalization. Med Care 1989, 27:1159-1166.
42. Morello C.M., Chynoweth M., Kim H., et al. Strategies to improve medication adherence reported by diabetes patients and caregivers: results of a Taking Control of Your Diabetes survey (February). Ann Pharmacother 2011, Feb 8. [Epub ahead of print].
43. Littenberg B., MacLean C.D., Hurowitz L. The use of adherence aids by adults with diabetes: a cross-sectional survey. BMC Fam Pract 2006, 7:1.
44. Are you taking medication as prescribed? FDA Consumer Health Information, Accessed March 5, 2011. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm164616.htm%23tips.
45. Medical device use-safety: incorporating human factors engineering into risk management US Department of Health and Human Services, Accessed March 5, 2011. http://medical.cms.itri.org.tw/pdf/u09.pdf.
46. Karter A.J., Parker M.M., Moffet H.H., et al. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res 2009, 44:1640-1661.
47. Harpe S.E. Using secondary data sources for pharmacoepidemiology and outcomes research. Pharmacotherapy 2009, 29:138-153.
48. Employer health benefits: 2010 annual survey Kaiser Family Foundation and Health Research & Educational Trust, Accessed March 5, 2011. http://ehbs.kff.org/.
49. Cramer J.A., Scheyer R.D., Prevey M.L., et al. Measuring compliance. JAMA 1989, 262:2091-2092.
50. Briesacher B.A., Andrade S.E., Fouayzi H., et al. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 2008, 28:437-443.
51. Boehringer Ingelheim Pharmaceuticals, Inc. 10 Steps to customer satisfaction: a special report. Supplement to Drug Store News: Pharmacy Practice Accessed April 2, 2011. http://www.cedrugstorenews.com/userapp/pdfs/BISupDrStNws31907%26CEQ407.pdf.
52. Polinski J.M., Schneeweiss S., Levin R., et al. Completeness of retail pharmacy claims data: implications for pharmacoepidemiologic studies and pharmacy practice in elderly patients. Clin Ther 2009, 31:2048-2059.
53. Batal H.A., Krantz M.J., Dale R.A., et al. Impact of prescription size on statin adherence and cholesterol levels. BMC Health Serv Res 2007, 7:175.
54. Ho P.M., Rumsfeld J.S., Masoudi F.A., et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006, 166:1836-1841.
55. Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) 1981, 282:1847-1851.